Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/EDITAS-MEDICINE-INC-26123639/noticia/Editas-Medicine-Inc-Recibe-la-designaci-n-de-medicamento-huerfano-de-la-FDA-para-el-EDIT-301-par-41621869/?utm_source=whatsapp&utm_medium=social&utm_campaign=share